New guidelines, developed and led by experts at the University of Nottingham, will help clinicians to better treat the ...

New guidelines published today, developed and led by experts at the University of Nottingham, will help clinicians to better ...

The new guidelines, developed for the British Society of Gastroenterology by academics at the Universities of Newcastle, ...

Explore how the Specialty Medical Home model transforms care for patients with inflammatory bowel disease (IBD) by ...

More information: James Edward East et al, British Society of Gastroenterology guidelines on colorectal surveillance in inflammatory bowel disease, Gut (2025). DOI: 10.1136/gutjnl-2025-335023 ...

Most US insurance companies require patients to fail conventional therapies for Crohn's disease and ulcerative colitis before they will cover a biologic agent, contrary to treatment guidelines.

Subcutaneous infliximab therapy alone is associated with higher immunogenicity than IV infliximab and an immunomodulator combined.

Read More: A Major Cause of Inflammatory Bowel Disease (IBD) Has Been Discovered The post Oxygen Chambers, Apple Watches May Help To Improve Treatment for Crohn's Disease, IBD, and Ulcerative ...

Acute severe ulcerative colitis is a severe complication of ulcerative colitis. The potentially life-threatening condition requires hospitalization for medication and, potentially, surgery.

Indeed, a review of studies on the use of immunosuppressive drugs called anti-TNF-α agents for IBD in a 2021 issue of BMC Gastroenterology found that remission occurred in only 45% percent of ...

Credit: Getty Images. Medications for ulcerative colitis include first-line therapy 5-ASA for mild cases as well as immune system–altering biologics for more severe cases. The initial treatment ...